Taken together, our data indicate that simultaneous suppression of MEK and Hh signaling has a more than additive effect on reduction of metastasis, particularly the post-extravasation tumor growth of pancreatic cancer, whereas single agents have limited effects. The gene discussed is MAP2K7; the disease is pancreatic neoplasm.